New RWE data base decision tree is now available

It is one single decision that typically decides whether results of your RealWorld Evidence Study are accepted:

No, it is not the study methodology, the way how you designed the cohorts or whether you follow the Trial Emulation
Approach in comparative research.

It is more simple: the decision which database to use is the single most important decision in a study.

The GIPAM team developed a decision tree that helps you in preparing this
important decision – the tree is based on a handful of questions and gives
you a concrete recommendation which data to use.

For further inquiries please contact us:
Thomas Wilke
info@gipam-health.com

Next
Next

Doing Real World Evidence Studies in addition to clinical trials is key for achieving a successful market access.